Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chairman & Chief Exec. Officer

Chief Financial Officer

President

See Remarks

VP, Commercial & Business Dev.

Chief Legal Officer

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-09-13	Premium	sold	Premium	Premium	Premium	Chairman & Chief Exec. Officer
2023-09-13	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-09-13	Premium	sold	Premium	Premium	Premium	President
2023-09-13	Premium	sold	Premium	Premium	Premium	See Remarks
2023-09-13	Premium	sold	Premium	Premium	Premium	VP, Commercial & Business Dev.
2023-09-12	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-09-12	Premium	acquired	Premium	Premium	Premium	VP, Commercial & Business Dev.
2023-09-12	Premium	acquired	Premium	Premium	Premium	President
2023-09-12	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-09-12	Premium	acquired	Premium	Premium	Premium	Chairman & Chief Exec. Officer
2023-06-14	Premium	sold	Premium	Premium	Premium	-
2023-06-14	Premium	sold	Premium	Premium	Premium	-
2023-06-14	Premium	sold	Premium	Premium	Premium	-
2023-06-14	Premium	sold	Premium	Premium	Premium	-
2023-06-14	Premium	sold	Premium	Premium	Premium	-
2023-06-14	Premium	sold	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-02-15	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-02-08	Premium	sold (taxes)	Premium	Premium	Premium	Chief Legal Officer
2023-02-08	Premium	sold (taxes)	Premium	Premium	Premium	VP, Commercial & Business Dev.

ZYNE - Zynerba Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ZYNE